These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33814640)

  • 1. Modeling and analysis of a within-host HIV/HTLV-I co-infection.
    Elaiw AM; AlShamrani NH
    Bol Soc Mat Mex; 2021; 27(2):38. PubMed ID: 33814640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a within-host HIV/HTLV-I co-infection model with immunity.
    Elaiw AM; AlShamrani NH
    Virus Res; 2021 Apr; 295():198204. PubMed ID: 33157165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of HTLV/HIV dual infection model with mitosis and latency.
    Elaiw AM; AlShamrani NH
    Math Biosci Eng; 2021 Jan; 18(2):1077-1120. PubMed ID: 33757177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of an HTLV/HIV dual infection model with diffusion.
    Elaiw AM; AlShamrani NH
    Math Biosci Eng; 2021 Oct; 18(6):9430-9473. PubMed ID: 34814353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity.
    AlShamrani NH
    Adv Differ Equ; 2021; 2021(1):270. PubMed ID: 34054935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
    Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
    Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of HIV-1/HTLV-I Co-Infection Model with Humoral Immunity and Cellular Infection.
    AlShamrani NH; Alshaikh MA; Elaiw AM; Hattaf K
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread.
    Kalinichenko S; Komkov D; Mazurov D
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability analysis of general delayed HTLV-I dynamics model with mitosis and CTL immunity.
    Elaiw AM; Shflot AS; Hobiny AD
    Math Biosci Eng; 2022 Aug; 19(12):12693-12729. PubMed ID: 36654018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of an adaptive immunity delayed HIV infection model with active and silent cell-to-cell spread.
    Elaiw AM; AlShamrani NH; Hobiny AD
    Math Biosci Eng; 2020 Sep; 17(6):6401-6458. PubMed ID: 33378861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Infection and Cancer: Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1, and Other Oncogenic Viruses.
    Mulherkar TH; Gómez DJ; Sandel G; Jain P
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
    Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
    Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
    Shuh M; Beilke M
    Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.